PTEN c.472_474delinsTTT ;(p.V158F)

Variant ID: 10-89692988-GTA-TTT

NM_000314.4(PTEN):c.472_474delinsTTT;(p.V158F)

This variant was identified in 11 publications

View GRCh38 version.




Publications:


A Review of Margetuximab-Based Therapies in Patients with HER2-Positive Metastatic Breast Cancer.

Cancers
Alasmari, Moudi M MM
Publication Date: 2022-12-21

Variant appearance in text: PTEN: V158F
PubMed Link: 36612034
Variant Present in the following documents:
  • Main text
  • cancers-15-00038.pdf
View BVdb publication page



Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases.

Scientific Reports
Šimčíková, Daniela D; Heneberg, Petr P
Publication Date: 2019-12-09

Variant appearance in text: PTEN: V158F
PubMed Link: 31819097
Variant Present in the following documents:
  • 41598_2019_54976_MOESM2_ESM.xlsx, sheet 8
View BVdb publication page



Immune Resistance and EGFR Antagonists in Colorectal Cancer.

Cancers
Giordano, Guido G; Remo, Andrea A; Porras, Almudena A; Pancione, Massimo M
Publication Date: 2019-07-31

Variant appearance in text: PTEN: V158F
PubMed Link: 31370270
Variant Present in the following documents:
  • Main text
  • cancers-11-01089.pdf
View BVdb publication page



The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy.

Nature Reviews. Cancer
Havel, Jonathan J JJ; Chowell, Diego D; Chan, Timothy A TA
Publication Date: 2019-03

Variant appearance in text: PTEN: V158F
PubMed Link: 30755690
Variant Present in the following documents:
  • Main text
View BVdb publication page



Strategies for Predicting Response to Checkpoint Inhibitors.

Current Hematologic Malignancy Reports
Zappasodi, Roberta R; Wolchok, Jedd D JD; Merghoub, Taha T
Publication Date: 2018-10

Variant appearance in text: PTEN: V158F
PubMed Link: 30159703
Variant Present in the following documents:
  • Main text
View BVdb publication page



Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer.

Plos One
Collins, Denis D; Jacob, Wolfgang W; Cejalvo, Juan Miguel JM; Ceppi, Maurizio M; James, Ian I; Hasmann, Max M; Crown, John J; Cervantes, Andrés A; Weisser, Martin M; Bossenmaier, Birgit B
Publication Date: 2017

Variant appearance in text: PTEN: V158F
PubMed Link: 28493933
Variant Present in the following documents:
  • pone.0177331.s002.pdf
View BVdb publication page



Evaluation of antibody-dependent cell-mediated cytotoxicity activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients.

World Journal Of Gastrointestinal Oncology
Lo Nigro, Cristiana C; Ricci, Vincenzo V; Vivenza, Daniela D; Monteverde, Martino M; Strola, Giuliana G; Lucio, Francesco F; Tonissi, Federica F; Miraglio, Emanuela E; Granetto, Cristina C; Fortunato, Mirella M; Merlano, Marco Carlo MC
Publication Date: 2016-02-15

Variant appearance in text: PTEN: V158F
PubMed Link: 26909137
Variant Present in the following documents:
  • Main text
View BVdb publication page



Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome.

Journal Of Translational Medicine
Calemma, Rosa R; Ottaiano, Alessandro A; Trotta, Anna Maria AM; Nasti, Guglielmo G; Romano, Carmela C; Napolitano, Maria M; Galati, Domenico D; Borrelli, Pasquale P; Zanotta, Serena S; Cassata, Antonino A; Castello, Giuseppe G; Iaffaioli, Vincenzo Rosario VR; Scala, Stefania S
Publication Date: 2012-11-21

Variant appearance in text: PTEN: V158F
PubMed Link: 23171437
Variant Present in the following documents:
  • 1479-5876-10-232.pdf
View BVdb publication page



Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer.

British Journal Of Cancer
Di Fiore, F F; Sesboüé, R R; Michel, P P; Sabourin, J C JC; Frebourg, T T
Publication Date: 2010-12-07

Variant appearance in text: PTEN: V158F
PubMed Link: 21139621
Variant Present in the following documents:
  • Main text
  • 6606008a.pdf
View BVdb publication page



Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer.

World Journal Of Gastroenterology
Saridaki, Zacharenia Z; Georgoulias, Vassilis V; Souglakos, John J
Publication Date: 2010-03-14

Variant appearance in text: PTEN: V158F
PubMed Link: 20222160
Variant Present in the following documents:
  • Main text
View BVdb publication page



Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors.

Journal Of Oncology
Egloff, Ann Marie AM; Grandis, Jennifer Rubin JR
Publication Date: 2009

Variant appearance in text: PTEN: V158F
PubMed Link: 19636423
Variant Present in the following documents:
  • Main text
  • JO2009-896407.pdf
View BVdb publication page